Skip to main content
Erschienen in: Pediatric Rheumatology 1/2013

Open Access 01.11.2013 | Meeting abstract

PW03-028 – Atypical presentation of CRMO in two children

Erschienen in: Pediatric Rheumatology | Sonderheft 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disorder that manifests as recurrent flares of inflammatory bone pain, related to one or more foci of nonbacterial osteomyelitis. Patients may present with low grade fever and modest elevation of the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and white blood cell counts (WBC). We describe two cases of chronic recurrent multifocal osteomyelitis with high fever and pronounced elevation of inflammatory parameters.

Case report

The first case was an 8-year-old boy presenting to the hospital with polyarticular pain, limping, fever, decreased appetite, weight loss and fatigue. CRP was 171mg/l, ESR 81mmh, WBC 16.5 G/l with 85% of neutrophils. We could exclude an infectious origin and suspected systemic onset juvenile idiopathic arthritis (SoJIA). The patient responded well to NSAIDs, and after discontinuation he showed a stiff neck without history of trauma. Cervical MRI showed C2 and C4 vertebral compaction with bone oedema. Total body MRI showed right distal femoral, right distal fibular and left acetabular enhancement. CRMO was suspected and a fibular biopsy, performed to rule out a tumour, showed fibrous remodelling of the bone, supporting the diagnosis of CRMO. NSAIDs were restarted with progressive improvement. A follow up MRI 6 months later showed decrease of cervical vertebrae oedema.
The second case was a 7-year-old boy with 2 weeks of high fever, decreased appetite, and weight loss without perspiration or chills. Blood parameters showed CRP 105 mg/l, ESR 72 mm/h and thrombocytosis 651 G/l. WBC was normal. Infectious and onco-haematological origines were excluded. A few days later he complained about left wrist pain. An MRI showed a significant periosteal reaction of the two bones of the forearm, associated with soft tissue involvement. Bone scintigraphy revealed hypercaptation of both forearms suggesting CRMO. Bone biopsy showed no inflammation or other abnormalities. Under NSAIDs, the patient did not improve and the biological parameters remained elevated. Because of the persistence of high fever and significant systemic inflammation a treatment with Anakinra, interleukin-1 (IL-1) receptor antagonist, was started, and induced rapid improvement of both bone pain and fever. When Anakinra was discontinued, inflammatory parameters increased again, without fever or other symptoms. A total body MRI was performed and showed multiple symmetrical enhancements in different skeletal segments.

Discussion

The two cases described showed an atypical presentation of CRMO, with high fever and increased inflammatory parameters suggesting a SoJIA. Interestingly, the second case responded to IL-1 blockade, suggesting a role for this cytokine in the disease. Another genetic syndrome, DIRA (deficiency of interleukin-1 receptor antagonist), presents with a similar phenotype to CRMO and could suggest an overlapping of these diseases with a key role of IL-1 in disease pathogenesis.

Disclosure of interest

None declared
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literatur
1.
Zurück zum Zitat Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C: Chronic recurrent multifocal osteomyelitis. Joint Bone Spine. 2011, 78 (6): 555-60. ReviewCrossRefPubMed Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C: Chronic recurrent multifocal osteomyelitis. Joint Bone Spine. 2011, 78 (6): 555-60. ReviewCrossRefPubMed
2.
Zurück zum Zitat Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, van Gijn ME: Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin Exp Rheumatol. 2011, 29 (6): 1040-3.PubMed Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, van Gijn ME: Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin Exp Rheumatol. 2011, 29 (6): 1040-3.PubMed
Metadaten
Titel
PW03-028 – Atypical presentation of CRMO in two children
Publikationsdatum
01.11.2013
Erschienen in
Pediatric Rheumatology / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A254

Weitere Artikel der Sonderheft 1/2013

Pediatric Rheumatology 1/2013 Zur Ausgabe

Meeting abstract

P02-029 - CAPS or SJIA

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.